Susan Kling Finston is a key opinion leader (KOL) on innovation, assimilation, and commercialization of new technologies to create social and economic benefit, with a deep understanding of government procurement and broader business development opportunities for bioscience and related R&D programs. Her substantive experience includes evaluating projects relating to renewable energy, energy efficiency, and other low-carbon technologies.
With 25+ years of work experience at the top echelons of corporations and government, Susan’s transformational vision yields consistent dividends for clients. Milestones include licensing and commercialization transactions over $20M, market access, and strategic partnering agreements for Fortune 100 companies. She also has completed successful engagements for corporate clients in the Trans-Pacific Partnership (TPP), Convention on Biological Diversity (CBD), World Health Organization (WHO), World Intellectual Property Organization (WIPO), and World Trade Organization (WTO). She has served as a cleared advisor (Secret level) to the Commerce Department and the U.S. Trade Representative (IPR, Tariff/Trade Facilitation) and served in the U.S. Foreign Service, Department of State with Top Secret and Code Word (compartmentalized) clearance levels. She has founded and/or co-founded several companies and NGOs with visionary leaders, including biotech pioneer Ananda Chakrabarty, Ph.D.
She earned her Joint Degree J.D./M.P.P. from the University of Michigan Law School & Ford School of Public Policy.